Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.

To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice.

Detalhes bibliográficos
Autores: Martínez-Moragón E, Climent M, Chiner E, Fernández-Aracil C, Sánchez-Toril F, Lluch-Tortajada I
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p3540
Acesso em linha:https://isabial.portalinvestigacion.com/publicaciones3540
Access Level:acceso abierto
Palavra-chave:Asthma
Cost-benefit analysis
Health care costs
Omalizumab
Quality of life
id ES_bf5cf0f954402a7e7642ef0424d97fca
oai_identifier_str oai:isabial.fundanetsuite.com:p3540
network_acronym_str ES
network_name_str España
repository_id_str
spelling Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.Martínez-Moragón ECliment MChiner EFernández-Aracil CSánchez-Toril FLluch-Tortajada IAsthmaCost-benefit analysisHealth care costsOmalizumabQuality of lifeTo assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice.ELSEVIER SCIENCE INC2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones3540FARMACIA HOSPITALARIAISSN: 11306343ISSNe: 21718695reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Inglésinfo:eu-repo/semantics/openAccessoai:isabial.fundanetsuite.com:p35402026-06-12T10:20:37Z
dc.title.none.fl_str_mv Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
title Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
spellingShingle Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
Martínez-Moragón E
Asthma
Cost-benefit analysis
Health care costs
Omalizumab
Quality of life
title_short Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
title_full Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
title_fullStr Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
title_full_unstemmed Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
title_sort Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.
dc.creator.none.fl_str_mv Martínez-Moragón E
Climent M
Chiner E
Fernández-Aracil C
Sánchez-Toril F
Lluch-Tortajada I
author Martínez-Moragón E
author_facet Martínez-Moragón E
Climent M
Chiner E
Fernández-Aracil C
Sánchez-Toril F
Lluch-Tortajada I
author_role author
author2 Climent M
Chiner E
Fernández-Aracil C
Sánchez-Toril F
Lluch-Tortajada I
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Asthma
Cost-benefit analysis
Health care costs
Omalizumab
Quality of life
topic Asthma
Cost-benefit analysis
Health care costs
Omalizumab
Quality of life
description To assess socio-sanitary expenditure after the addition of omalizumab to standard treatment in the control of severe asthma and to analyse its effectiveness under standard clinical practice.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones3540
url https://isabial.portalinvestigacion.com/publicaciones3540
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER SCIENCE INC
publisher.none.fl_str_mv ELSEVIER SCIENCE INC
dc.source.none.fl_str_mv FARMACIA HOSPITALARIA
ISSN: 11306343
ISSNe: 21718695
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418363041611776
score 15.812455

Registos relacionados